Published on 5 Feb 2023 on Simply Wall St. via Yahoo Finance
We feel now is a pretty good time to analyse CloudMD Software & Services Inc.'s (CVE:DOC) business as it appears the company may be on the cusp of a considerable accomplishment. CloudMD Software & Services Inc. operates as a healthcare technology company in North America. The company’s loss has recently broadened since it announced a CA$31m loss in the full financial year, compared to the latest trailing-twelve-month loss of CA$152m, moving it further away from breakeven. The most pressing concern for investors is CloudMD Software & Services' path to profitability – when will it breakeven? In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.
See our latest analysis for CloudMD Software & Services
Consensus from 6 of the Canadian Healthcare analysts is that CloudMD Software & Services is on the verge of breakeven. They expect the company to post a final loss in 2022, before turning a profit of CA$17m in 2023. The company is therefore projected to breakeven around 12 months from now or less. How fast will the company have to grow to reach the consensus forecasts that anticipate breakeven by 2023? Working backwards from analyst estimates, it turns out that they expect the company to grow 91% year-on-year, on average, which signals high confidence from analysts. Should the business grow at a slower rate, it will become profitable at a later date than expected.